© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
International Parkinson and Movement Disorders Society Congress
Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhD
October 01, 2021
The expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]
Highlighting the Significant Strides Made in Friedreich Ataxia Care
October 01, 2021
David R. Lynch, MD, PhD, professor of neurology, University of Pennsylvania Perelman School of Medicine, discussed why omaveloxolone’s recent success speaks to the progress made within the FA treatment space.
Cala Trio TAPS Device Reduces Severe Tremor in Patients With ET
September 30, 2021
When used for at least 30 days, it was reported that patients with essential tremor reported improvement in tremor power following 54% of sessions.
NeuroVoices: David R. Lynch, MD, PhD, on the First Potentially Approved Friedreich Ataxia Treatment
September 29, 2021
The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed the state of care for Friedrich ataxia and omaveloxolone’s potential to become its first approved therapy.
Takeaways From MDS 2021: Lisanne Dommershuijsen, MSc
September 27, 2021
Following her presentation at MDS 2021, the PhD candidate in epidemiology at Erasmus University Medical Center discussed highlights from this year’s virtual congress. [WATCH TIME: 2 minutes]
Mechanistic Action and FDA Outlook for Omaveloxolone in Friedreich Ataxia: David R. Lynch, MD, PhD
September 27, 2021
The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed whether omaveloxolone’s therapeutic benefit is enough for it to become the first approved therapy for Friedrich ataxia. [WATCH TIME: 2 minutes]
Developing Interventions to Address Mental Health in Parkinson Disease: Lisanne Dommershuijsen, MSc
September 26, 2021
The PhD candidate in the epidemiology department at Erasmus University Medical Center in the Netherlands discussed the need for tailored treatment in light of the COVID-19 pandemic. [WATCH TIME: 4 minutes]
MDS Congress 2021: Highlights, Takeaways, and Future Research
September 26, 2021
Following MDS 2021, we compiled a roundup of some of our discussions with experts in the Parkinson disease and movement disorders space in one convenient location.
COVID-19 Stressors and Mental Health in Parkinson Disease: Lisanne Dommershuijsen, MSc
September 25, 2021
The PhD candidate in the epidemiology department at Erasmus University Medical Center in the Netherlands discussed the need for tailored treatment in light of the COVID-19 pandemic. [WATCH TIME: 4 minutes]
Victor Sung, MD, on the Cost of Genetic Testing for Huntington Disease
September 24, 2021
The director of the UAB Huntington's Disease Clinic offered his insight on a recent assessment of HD genetic testing at HDSA Centers of Excellence, and the associated costs for patients.